Session Datesort descending
Safety and Synergy of Stereotactic Radiotherapy for Oligometastases; Alexander Louie, MD 01/10/2023 - 12:00pm to 1:00pm CST
Renaissance of Radiotherapy for Renal Cell Carcinoma; Shankar Siva, MD 02/07/2023 - 12:00pm to 1:00pm CST
Imaging in BMT; Jennifer Holter-Chakrabarty, MD 03/07/2023 - 12:00pm to 1:00pm CST
Genomic and Epigenomic studies of Cholangiocarcinoma and its Clinical Implications; Bin Tean Teh, MD 04/04/2023 - 12:00pm to 1:00pm CDT
Immune Checkpoint Blockade-Associated Acute Kidney Injury and Transplant Rejection; Naoka Murakami, MD 05/02/2023 - 12:00pm to 1:00pm CDT
Opening the Therapeutic Window: The Future of Normal Tissue Spacing; Dr. Peter Orio III 06/13/2023 - 12:00pm to 1:00pm CDT
From the Clinic to the Lab: Investigating Mechanisms of Response and Resistance to Immune Checkpoint Therapy; Padmanee Sharma, MD, PhD 07/11/2023 - 12:00pm to 1:00pm CDT
Use of Radiotherapy to Modulate the Immune System in Melanoma, Myeloma and Covid-19 ARDS Patients; Mohammad Khan, MD, PhD 08/01/2023 - 12:00pm to 1:00pm CDT
Optimization of Risk and Reward with Ablative and Near-Ablative Radiotherapy; Robert Timmerman, MD 09/12/2023 - 12:00pm to 1:00pm CDT
Resection and Transplantation for Intra-Hepatic Cholangiocarcinoma (iCCA); Vicenzo Mazzaferro, MD, PhD 10/03/2023 - 12:00pm to 1:00pm CDT

Pages